ESTAEstablishment Labs Holdings Inc

Establishment Labs (NASDAQ:ESTA) reported first-quarter 2026 revenue of $59.9 million and adjusted EBITDA of $1.2 million, marking what Chief Executive Officer Peter Caldini described as "a strong start to the year." Revenue increased 45% versus the prior-year period, and the company posted its thir...

Establishment Labs (ESTA) delivered earnings and revenue surprises of -40.35% and +4.15%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving womens health and wellness, principally in breast aesthetics and reconstruction, today...

Establishment Labs Holdings Inc. (NASDAQ:ESTA - Get Free Report) Director Quiros Juan Jose Chacon sold 7,751 shares of the firm's stock in a transaction dated Monday, May 4th. The stock was sold at an average price of $70.48, for a total transaction of $546,290.48. Following the sale, the director...

Establishment Labs Holdings Inc. (NASDAQ:ESTA - Get Free Report) Director Quiros Juan Jose Chacon sold 67,249 shares of Establishment Labs stock in a transaction that occurred on Friday, May 1st. The shares were sold at an average price of $70.78, for a total transaction of $4,759,884.22. Following...

Kornitzer Capital Management Inc. KS reduced its position in shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA - Free Report) by 33.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 118,920 shares of the c...

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving womens health and wellness, principally in breast aesthetics and reconstruction, today...

Establishment Labs (NASDAQ:ESTA) will be releasing its Q1 2026 earnings after the market closes on Wednesday, May 6. (View Earnings Report at...

Establishment Labs Holdings Inc. (NASDAQ:ESTA - Get Free Report) Director Quiros Juan Jose Chacon sold 2,180 shares of the business's stock in a transaction on Monday, April 27th. The shares were...